# ANTARES PHARMA, INC. hires BURRELL INTERNATIONAL GROUP LLC (Budget/Appropriations, Defense)

**Score:** 60/100

| Field | Value |
|---|---|
| Client | ANTARES PHARMA, INC. |
| Client description | Specialty pharmaceutical company |
| Client state | NJ |
| Lobbying firm | BURRELL INTERNATIONAL GROUP LLC |
| Firm state | DC |
| Issue areas | Budget/Appropriations, Defense |
| Specific matters disclosed | Testosterone replacement therapy; FY28 Defense Authorization and Appropriations. · Testosterone replacement therapy; FY28 Defense Authorization and Appropriations. |
| Registered | 2026-10-01 |

## Why this score
- Lobbying on several issue areas.
- Specific matters disclosed.

Source: U.S. Senate and House Lobbying Disclosure Act (LDA) filings via lda.gov; Colorado Secretary of State, NYC City Clerk eLobbyist and City of Chicago Board of Ethics lobbying data (https://lda.gov/filings/public/filing/537ccb24-320b-48fa-b553-9b588f31b625/print/). Last refreshed: 2026-11-03T19:42:41.566Z.
From public Lobbying Disclosure Act registrations (lda.gov) and Colorado, New York City and City of Chicago lobbying disclosures. Organization level only: we never list lobbyist, CEO or contact names, and clients whose name reads as a person are left out. Chicago amounts are lobbyist compensation reported for the quarter, summed by client. A registration reports intent to lobby; it is not evidence of wrongdoing.